153 related articles for article (PubMed ID: 2673590)
1. Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.
Fine PE; Gruer PJ; Maine N; Ponnighaus JM; Rees RJ; Stanford JL
Clin Exp Immunol; 1989 Aug; 77(2):226-9. PubMed ID: 2673590
[TBL] [Abstract][Full Text] [Related]
2. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J
Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210
[TBL] [Abstract][Full Text] [Related]
3. Studies on lepromin and soluble antigens of M.leprae: their classification standardization and use.
Sengupta U
Indian J Lepr; 1991; 63(3-4):457-65. PubMed ID: 1804898
[TBL] [Abstract][Full Text] [Related]
4. Studies on the antigenic specificity of Mycobacterium leprae. II. Purification and immunological characterization of the soluble antigen in leprosy nodules.
Abe M; Minagawa F; Yoshino Y; Okamura K
Int J Lepr Other Mycobact Dis; 1972; 40(2):107-17. PubMed ID: 4119113
[No Abstract] [Full Text] [Related]
5. Experiences with Mycobacterium leprae soluble antigens in a leprosy endemic population.
Gupte MD; Anantharaman DS; Nagaraju B; Kannan S; Vallishayee RS
Lepr Rev; 1990 Jun; 61(2):132-44. PubMed ID: 2198413
[TBL] [Abstract][Full Text] [Related]
6. Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae.
Gill HK; Mustafa AS; Godal T
Bull World Health Organ; 1986; 64(1):121-6. PubMed ID: 3524883
[TBL] [Abstract][Full Text] [Related]
7. Soluble antigen of M. leprae coupled with liposomes elicits both "early" and "late" delayed hypersensitivity skin reactions.
Sengupta U; Sinha S; Ramu G; Lavania RK; Gupta CM
Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):45-9. PubMed ID: 3286800
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
Kaplan G; Gandhi RR; Weinstein DE; Levis WR; Patarroyo ME; Brennan PJ; Cohn ZA
J Immunol; 1987 May; 138(9):3028-34. PubMed ID: 3106496
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the Mitsuda reaction to Mycobacterium leprae can be mediated by lymphocytes responsive to Mycobacterium tuberculosis.
Roberts PP; Dockrell HM; McAdam KP
Clin Exp Immunol; 1988 Jun; 72(3):390-3. PubMed ID: 2458870
[TBL] [Abstract][Full Text] [Related]
10. [Delayed cutaneous response to different antigens in household contacts of leprosy patients and controls].
Bottasso O; Poli HO; Morini JC
Med Cutan Ibero Lat Am; 1987; 15(6):504-10. PubMed ID: 3323710
[TBL] [Abstract][Full Text] [Related]
11. Microscopic findings of delayed reactions elicited by the skin test reagent Leprosin A derived from M. leprae.
Samuel NM; Stanford JL; Desikan KV
Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):395-403. PubMed ID: 3900246
[TBL] [Abstract][Full Text] [Related]
12. A quantitative study of the relationship between systemic and histological parameters of immunity in individual leprosy patients.
Cree IA; Smith WC; Beck JS
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):347-52. PubMed ID: 2198317
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of immunizing and delayed hypersensitivity eliciting antigens of Mycobacterium leprae, M. tuberculosis, M. vaccae, and M. bovis (BCG).
Sinha S; Sreevatsa ; Gupta SK; Sengupta U
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):42-53. PubMed ID: 2435824
[TBL] [Abstract][Full Text] [Related]
14. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
Laal S; Mishra RS; Nath I
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
[TBL] [Abstract][Full Text] [Related]
15. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
[TBL] [Abstract][Full Text] [Related]
16. Use of non-conventional antigen: M. habana in detecting M. leprae antibodies from leprosy patients and contacts in FLA-ABS test.
Rana NS; Gupta HP; Singh NB
Indian J Lepr; 1988 Oct; 60(4):593-9. PubMed ID: 3075637
[TBL] [Abstract][Full Text] [Related]
17. Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.
Kaplan G; Sampaio EP; Walsh GP; Burkhardt RA; Fajardo TT; Guido LS; de Miranda Machado A; Cellona RV; Abalos RM; Sarno EN
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6269-73. PubMed ID: 2668961
[TBL] [Abstract][Full Text] [Related]
18. Relative cross reactivity of habanin, lepromin and tuberculin in guinea pigs sensitized with homologous and heterologous mycobacteria.
Singh NB; Srivastava A; Gupta HP; Kumar A; Chaturvedi VK
Indian J Lepr; 1988 Jul; 60(3):407-12. PubMed ID: 3143770
[TBL] [Abstract][Full Text] [Related]
19. Effect of skin test with M. leprae soluble antigen on reaction to a subsequent test with the same antigen.
Gupte MD; Vallishayee RS; Anantharaman DS; Kannan S
Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):54-60. PubMed ID: 1602194
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of skin tests and the production of gamma-interferon in leprosy patients].
Suso L; Nogueira N; Vieira LM; Figueiredo AA; Porto JA; Sarno EN
Med Cutan Ibero Lat Am; 1988; 16(3):193-6. PubMed ID: 3143869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
